Results 1 to 10 of about 3,447,958 (308)

Experimental study on inhibition of coal spontaneous combustion by hydroxyethylene diphosphonic acid

open access: yesMeikuang Anquan, 2022
In order to study the effect of hydroxyethylene diphosphonic acid(HEDP) on the characteristics of coal spontaneous combustion, a temperature-programmed gas chromatography experiment was carried out to compare and analyze the production and development of
SUN Meng   +3 more
doaj   +1 more source

The selective inhibition of the Syk tyrosine kinase ameliorates experimental autoimmune arthritis

open access: yesFrontiers in Immunology, 2023
Autoimmune arthritis – such as rheumatoid arthritis – affect a significant proportion of the population, which can cause everyday joint pain, decreased mobility and reduced quality of life.
Eszter Káposztás   +11 more
doaj   +1 more source

Digital Holography Study of the Inhibitory Effects of Polyaspartic Acid on the Anodic Dissolution of Inconel® 600

open access: yesElectrochemistry, 2021
Electrochemical methods were used in conjunction with digital holography to study the effects of an environmentally friendly inhibitor, polyaspartic acid (PASP), on the anodic dissolution of Inconel® 600 in a 0.04 M HCl solution.
Yu SHAO   +4 more
doaj   +1 more source

Development of a CDK10/CycM in vitro Kinase Screening Assay and Identification of First Small-Molecule Inhibitors

open access: yesFrontiers in Chemistry, 2020
Cyclin-dependent kinases (CDKs) constitute a family of 20 serine/threonine protein kinases that play pivotal roles in the regulation of numerous important molecular and cellular processes. CDKs have long been considered promising therapeutic targets in a
Thomas Robert   +8 more
doaj   +1 more source

A novel autophagy inhibitor, bTBT, disturbs autophagosome formation

open access: yesAutophagy Reports, 2023
Macroautophagy (hereafter, autophagy) is a form of intracellular degradation in which autophagosome formation is systematically coordinated by multiple processes involving numerous autophagy-related gene (ATG) proteins. Autophagy-modulating compounds are
Momoka Chiba   +6 more
doaj   +1 more source

Discovery of novel spike/ACE2 inhibitory macrocycles using in silico reinforcement learning

open access: yesFrontiers in Drug Discovery, 2022
Introduction: The COVID-19 pandemic has cast a heavy toll in human lives and global economics. COVID-19 is caused by the SARS-CoV-2 virus, which infects cells via its spike protein binding human ACE2.Methods: To discover potential inhibitory ...
Lev Shapira   +9 more
doaj   +1 more source

Characterization and translational development of IOA-289, a novel autotaxin inhibitor for the treatment of solid tumors

open access: yesImmuno-Oncology and Technology, 2023
Background: Autotaxin-lysophosphatidic acid (ATX-LPA) signaling has a predominant role in immunological and fibrotic processes, including cancer. Several ATX inhibitors and LPA receptor antagonists have been clinically evaluated, but none in patients ...
M.A. Deken   +16 more
doaj   +1 more source

Extracts from European Propolises as Potent Tyrosinase Inhibitors

open access: yesMolecules, 2022
Tyrosinase is a key enzyme in the melanogenesis pathway. Melanin, the product of this process, is the main pigment of the human skin and a major protection factor against harmful ultraviolet radiation (UVR).
Jarosław Widelski   +7 more
doaj   +1 more source

DPP8 Selective Inhibitor Tominostat as a Novel and Broad-Spectrum Anticancer Agent against Hematological Malignancies

open access: yesCells, 2023
DPP8/9 inhibition induces either pyroptotic or apoptotic cell death in hematological malignancies. We previously reported that treatment with the DPP8/9 inhibitor 1G244 resulted in apoptotic cell death in myeloma, and our current study further evaluates ...
Shohei Kikuchi   +21 more
doaj   +1 more source

AKT activation controls cell survival in response to HDAC6 inhibition. [PDF]

open access: yes, 2016
HDAC6 is emerging as an important therapeutic target for cancer. We investigated mechanisms responsible for survival of tumor cells treated with a HDAC6 inhibitor.
Aboagye, EO   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy